Expression of Sialosyl-T and Disialosyl-T Antigens in Erythroid Cells

References

• Robinson J., Sieff C., Deilia D., Edwards P. A. W., Greaves M. Expression of cell surface HLA‐DR, HLA‐ABC and glycophorin during eryrthroid differentiation. Nature 1981; 289: 68–71
   PubMed Web of Science ®Google Scholar
• Loken M. R., Shah V. O., Dattilio K. L., Civin C. I. Flow cytometric analysis of human bone marrow: I. Normal erythroid development. Blood 1987; 69: 255–263
   PubMed Web of Science ®Google Scholar
• Thomas D. B., Winzler R. J. Structural studies on human erythrocyte glycoproteins: Alkali‐labile oligosaccharides. J. Biol. Chem. 1969; 244: 5943–5946
   PubMed Web of Science ®Google Scholar
• Clausen H., Stroud M. R., Parker J., Springer G., Hakomori S. Monoclonal antibodies directed to the blood group A associated structure, galactosyl‐A: specificity and relation to the Thomas‐Friedenreich antigen. Mot. Immunol 1989; 25: 199–204
   Web of Science ®Google Scholar
• Fukuda M., Lauffenburger M., Sasaki H., Rogers M. E., Dell A. Structures of novel sialylated 0‐linked oligosaccharides isolated from human erythrocyte gly‐cophorins. J. Biol. Chem. 1987; 262: 11952–11957
   PubMed Web of Science ®Google Scholar
• Hakomori S. Aberrant glycosylation in tumors and tumor‐associated carbohydrate antigens. Adv. Cancer. Res. 1989; 52: 258–331
   Google Scholar
• Singhal A., Hakomori S. Molecular changes in carbohydrate antigens associated with cancer. BioEssays 1990; 12: 223–230
   PubMed Web of Science ®Google Scholar
• Hurwitz C. A., Loken M. R., Graham M. L., Karp J. E., Borowitz M. J., Pullen D. J., Civin C. I. Asynchronous antigen expression in B lineage acute lymphoblastic leukemia. Blood 1988; 72: 299–307
   PubMed Web of Science ®Google Scholar
• Terstappen L. W.M.M., Safford M., Konemann S., Loken M. R., Zurlutter K., Buchner T., Hiddemann W., Wormann B. Flow cytometric characterization of acute myeloid leukemia. Part II. Phenotype heterogeneity at diagnosis. Leukemia 1991; 5: 757–767
   Web of Science ®Google Scholar
• Peters R. E., Janossy G., Ivory K., Al‐Ismail S., Mercolino T. Leukemia‐associated changes identified by quantitative flow cytometry. III. B‐cell gating in CD37/κ/λ. clonality test. Leukemia 1994; 8: 1864–1870
   PubMed Web of Science ®Google Scholar
• Bednarek J. M., Knight R. D., Taylor G., Evans W. H. Progressive loss of phenotypic proteins in mature granulocytes before the onset of blastic crisis in humn chronic myelogenous leukemia. J. Natl. Cancer. Inst. 1988; 80: 251–257
   PubMed Web of Science ®Google Scholar
• Rozman M., Cervantes F., Urbano‐Ispizua A., Feliu E., Vives‐Corrons J. L., Rozman C. Sequential study of myeloid differentiation antigens of neutrophil granulocytes in different phases of chronic myeloid leukemia: natural history and prognosis significance. Leukemia 1993; 7: 80–85
   PubMed Web of Science ®Google Scholar
• Saitoh O., Piller F., Fox R. I., Fukuda M. T‐lymphocytic leukemia expresses complex, branched O‐linked oligosaccharides on a major sialoglycoprotein, leukosialin. Blood 1991; 77: 1491–1499
   PubMed Web of Science ®Google Scholar
• Muroi K., Suda T., Nakamura M., Okada S., Nojiri H., Amemiya Y., Miura Y., Hakomori S. Expression of sialosyl‐Tn in colony‐forming unit‐erythroid, erythroblasts, B cells and a subset of CD4+ cells. Blood 1994; 83: 84–91
   PubMed Web of Science ®Google Scholar
• Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Gallon D. A. G., Gralnick H. R., Sultan C. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML‐MO). Br. J. Haematol. 1991; 78: 325–329
   PubMed Web of Science ®Google Scholar
• Saito S., Steven B. L., Salyan M. E. K., Goldberg R. I., Hakomori S. Common tetrasaccharide epitope NeuAcα2→3Galβ1→3(NeuAcα2→6)Ga1NAc, presented by different carrier glycosylceramides or O‐linked peptides, is recognized by different antibodies and ligands having distinct specificities. J. Biol. Chem. 1994; 269: 5644–5652
   PubMed Web of Science ®Google Scholar
• Stelzer G. Y., Shults K. E., Loken M. R. CD45 gating for routine flow cytometric analysis of human bone marrow specimens. Ann. N.Y. Acad. Sci. 1993; 677: 265–279
   PubMed Web of Science ®Google Scholar
• Loken M. R., Civin C. I., Shah V. O., Fackler M. J., Segers‐Nolten I., Terstappen L. W. M. M. Characterization of erythroid, lymphoid and monomyeloid lineages in normal human bone marrow. Flow Cytometry In Hematology, O. D. Laerum, R. Bjerknes. Academic Press, San Diego 1992; 31–42
   Google Scholar
• Gahmberg C. G., Ekblom M., Andersson L. C. Differentiation of human erythroid cells is associated with increased O‐glycosy lation of the major sialoglycoprotein, glycophorin A. Proc. Natl. Acad. Sci. USA 1984; 81: 6752–6756
   PubMed Web of Science ®Google Scholar
• Sieff C., Bicknell D., Caine G., Robinson J., Lam G., Greaves M. F. Changes in cell surface antigen exres‐sion during hemopoietic differentiation. Blood 1982; 60: 703–713
   PubMed Web of Science ®Google Scholar
• Levene R. B., Lamaziere J. M. D., Broxmeyer H. E.L., Rabellino E. M. Human megakaryocytes V. Changes in the phenotypic profile of differentiating megakaryocytes. J. Exp. Med. 1985; 161: 457–474
   PubMed Web of Science ®Google Scholar
• Okumura N., Tsuji K., Nakahata T. Changes in cell surface antigen expression during proliferation and differentiation of human erythroid progenitors. Blood 1992; 80: 642–650
   PubMed Web of Science ®Google Scholar
• Greaves M. F., Sieff C., Edwards P. A. W. Monoclonal anti‐glycophorin as a probe for erythroleukemias. Blood 1983; 61: 645–651
   PubMed Web of Science ®Google Scholar
• Villeval J. L., Cramer P., Lemoine A., Henri A., Bettaieb A., Bernaudin F., Beuzard Y., Berger R., Flandrin G., Breton‐Gorius J., Vainchenker W. Phenotype of early erythroblastic leukemias. Blood 1986; 68: 1167–1174
   PubMed Web of Science ®Google Scholar
• Ekert H., Sievers E. L., Tan A., Martin D. I. K., Smith F. O., Barnard D., Bernstein I. D. GATA‐1 is expressed in acute erythroblastic leukaemia. Br. J. Haematol. 1994; 86: 410–412
   PubMed Web of Science ®Google Scholar
• Cuneo A., Van Orshoven A., Michaux J. L., Boogaerts M., Louwagie A., Doyen C., Dal Cin P., Fagioli F., Castoldi G., Van Den Berghe H. Morphologic, immunologic and cytogenetic studies in erythroleukaemia: evidence for multilineage involvement and identification of two distinct cytogenetic‐clinicopathological types. Br. J. Haematol. 1990; 75: 346–354
   PubMed Web of Science ®Google Scholar
• Carlsson S. R., Fukuda M. Isolation and chracterization of leukosialin, a major sialoglycoprotein on human leukocytes. J. Biol. Chem. 1986; 261: 12779–12786
   PubMed Web of Science ®Google Scholar
• Remold‐O'Donnell E., Davis A. E., III, Kenney D., Bhaskar K. R., Rosen F. S. Purification and chemical composition of gpL 115, the human lymphocyte surface sialoglycoprotein that is defective in Wiskott‐Aldrich syndrome. J. Biol. Chem. 1986; 261: 7526–7530
   PubMed Web of Science ®Google Scholar
• Piller F., Piller V., Fox R. I., Fukuda M. T‐lymphocytic leukemia expresses complex, branched O‐linked oligosaccharides on a major sialoglycoprotein, leukosialin. Blood 1991; 77: 1491–1499
   PubMed Web of Science ®Google Scholar
• Carlsson S. R., Sasaki H., Fukuda M. Structural variations of O‐linked oligosaccharides present in leukosialin isolated from erythroid, myeloid, and T‐lymphoid cell lines. J. Biol. Chem. 1986; 261: 12787–12795
   PubMed Web of Science ®Google Scholar
• Maemura K., Fukuda M. Poly‐N‐acetyllac‐tosaminyl O‐glycans attached to leukosialin. J. Biol. Chem. 1992; 267: 24379–24386
   PubMedGoogle Scholar